Patent details

EP3880678 Title: CRYSTALLINE FORMS OF P2X3 MODULATOR METHYL (S)-2-((2-(2,6-DIFLUORO-4-(METHYLCARBAMOYL )PHENYL)-7-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL)METHYL)MORPHOLINE-4-CARBOXYLATE

Basic Information

Publication number:
EP3880678
PCT Application Number:
IB2019001199
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP198846115
PCT Publication Number:
WO2020099923
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CRYSTALLINE FORMS OF P2X3 MODULATOR METHYL (S)-2-((2-(2,6-DIFLUORO-4-(METHYLCARBAMOYL )PHENYL)-7-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL)METHYL)MORPHOLINE-4-CARBOXYLATE
French Title of Invention:
FORMES CRISTALLINES DU MODULATEUR P2X3 (S)-2-((2-(2,6-DIFLUORO-4-(MÉTHYLCARBAMOYL )PHÉNYL)-7-MÉTHYLIMIDAZO[1,2-A]PYRIDIN-3-YL)MÉTHYL)MORPHOLINE-4-CARBOXYLATE
German Title of Invention:
KRISTALLINE FORMEN DES P2X3-MODULATORS METHYL (S)-2-((2-(2,6-DIFLUORO-4-(METHYLCARBAMOYL )PHENYL)-7-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL)METHYL)MORPHOLIN-4-CARBOXYLAT
SPC Number:

Dates

Filing date:
12/11/2019
Grant date:
07/05/2025
EP Publication Date:
22/09/2021
PCT Publication Date:
22/05/2020
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/05/2025
EP B1 Publication Date:
07/05/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
12/11/2039
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/04/2025
 
 

Name:
GlaxoSmithKline Intellectual Property (No.3) Limited
Address:
GSK Medicines Research Centre Gunnels Wood Road, Stevenage SG1 2NY, United Kingdom (GB)

Inventor

1

Name:
CHAURET, Nathalie
Address:
Canada (CA)

2

Name:
PAYZA, Kemal
Address:
Canada (CA)

3

Name:
WENSLOW, Robert M.
Address:
Canada (CA)

4

Name:
GARCEAU, Denis
Address:
Canada (CA)

Priority

Priority Number:
201862760307 P
Priority Date:
13/11/2018
Priority Country:
United States (US)

Classification

IPC classification:
C07D 471/04; A61K 31/5377; A61P 11/14; A61P 13/00; A61P 15/00; A61P 17/04; A61P 29/00;

Publication

European Patent Bulletin

Issue number:
202519
Publication date:
07/05/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
01/12/2025
Annual Fee Number:
7
Annual Fee Amount:
82 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages